| 40862 |
A |
II |
2024/11/27
|
BEIJING SUMMIT CELL LIFE SCIENCE ENGINEERING RESEARCH INSTITUTE CO LTD |
HUMAN T CELL-DERIVED EXOSOMES |
| 40901 |
A |
II |
2024/11/27
|
SUZHOU RYWAY BIOTECH CO LTD |
CARBIMAZOLE |
| 40707 |
A |
IV |
2024/11/26
|
AMI LIFESCIENCES PRIVATE LTD |
SALCAPROZATE SODIUM |
| 40872 |
A |
II |
2024/11/26
|
SICHUAN ELIXIR PHARMACEUTICAL CO LTD |
RESMETIROM |
| 40902 |
A |
II |
2024/11/26
|
SUZHOU RYWAY BIOTECH CO LTD |
METHIMAZOLE |
| 40904 |
A |
II |
2024/11/26
|
SUZHOU RYWAY BIOTECH CO LTD |
PROPYLTHIOURACIL |
| 40357 |
A |
II |
2024/11/25
|
ZHEJIANG HENGKANG PHARMACEUTICAL CO LTD |
ELTROMBOPAG OLAMINE |
| 40745 |
A |
III |
2024/11/25
|
WUXI NEST BIOTECHNOLOGY CO LTD |
COP PREFILLED SYRINGE ASSEMBLY |
| 40758 |
A |
II |
2024/11/25
|
SICHUAN HUIYU PHARMACEUTICAL CO LTD |
CARFILZOMIB
|
| 40886 |
A |
II |
2024/11/25
|
SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD |
MENAQUINONE-4 |
| 40877 |
A |
II |
2024/11/23
|
RAJASTHAN ANTIBIOTICS LTD |
PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM STERILE (8:1) |
| 40412 |
A |
II |
2024/11/22
|
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER |
F18-FLUROROTHYMIDINE (F18-FLT) INJECTION |
| 40458 |
A |
IV |
2024/11/22
|
HEFEI TIANHUI BIOTECH CO LTD |
SOYBEAN TRYPSIN INHIBITOR (SBTI) |
| 40665 |
A |
II |
2024/11/22
|
TORRENT PHARMACEUTICALS LTD |
VERICIGUAT |
| 40775 |
A |
IV |
2024/11/22
|
GULSHAN POLYOLS LTD |
SORBITOL 70% SOLUTION CRYSTALLIZING AND NON- CRYSTALLIZING |
| 40787 |
A |
II |
2024/11/22
|
SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD |
LETERMOVIR |
| 40870 |
A |
II |
2024/11/22
|
SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD |
CHLORZOXAZONE |
| 40880 |
A |
IV |
2024/11/22
|
ANMOL CHEMICALS PVT LTD |
SODIUM CITRATE BP |
| 40882 |
A |
IV |
2024/11/22
|
ANMOL CHEMICALS PVT LTD |
SODIUM SELENITE BP |
| 40883 |
A |
IV |
2024/11/22
|
ANMOL CHEMICALS PRIVATE LTD |
CITRIC ACID (ANHYDROUS) BP |
请输入需要查询的关联主题/药物名称（英文），DMF持有人（英文），DMF号码